Both in Pharmaceuticals
Gyre Therapeutics vs Indaptus Therapeutics
Over the past year GYRE returned −38.8% and INDP returned +16.2%; their daily moves had a correlation of 0.17.
GYRE −38.8% INDP +16.2%Growth of $1, one year, split-adjusted
| Metric | GYRE | INDP |
|---|---|---|
| Price | $4.44 | $3.30 |
| Market cap | $470.8M | $439.7M |
| Today | 0.00% | +1.85% |
| 1 month | −37.3% | +27.4% |
| 6 months | −44.8% | +61.0% |
| Year to date | −37.1% | +13.4% |
| 1 year | −39.7% | +5.8% |
| Revenue growth (YoY) | −2.1% | — |
| Gross margin | 92.4% | — |
| Net margin | −40.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.9× | — |
| Net cash | $74.8M | $11.6M |
| Dividend yield | — | — |
| Volatility (60d) | 88.3% | 193.4% |
| Short % of float | 11.5% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).